Rights and permissions
About this article
Cite this article
Initiating prevention early benefits women with BRCA1/2 mutations. Pharmacoecon. Outcomes News 370, 7 (2002). https://doi.org/10.1007/BF03279289
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279289